Çмú´ëȸ ¹ßÇ¥ ¿¬Á¦ ÃÊ·Ï

¹ßÇ¥Çü½Ä : Á¢¼ö¹øÈ£ - 990070    RHPX06 
CASE REPORT OF SINONASAL PHOSPHATURIC MESENCHYMAL TUMOUR: IMPLICATION OF TREATMENT DEFAULT
DEPT OF OTORHINOLARYNGOLOGY - HEAD AND NECK SURGERY, CHANGI GENERAL HOSPITAL, SINGAPORE
KAVIMALAR RAVI, KAVIMALAR RAVI, DAVID LOW YONG MING, LEE TEE SIN, MARIA J. PANG CUI-YING
Phosphaturic mesenchymal tumours (PMT) in the sinonasal region are rare. Patients can present with local nasal symptoms or with systemic symptoms of tumour induced osteomalacia. Distinctive histological features and biochemical derangements aid clinicians in the diagnosis. We report a case of a 45 year old female who presented with sinonasal PMT and consequent tumour induced osteomalacia in our institution. The patient was diagnosed to have sinonasal PMT in the left nasal cavity after presenting with epistaxis. She subsequently defaulted clinical follow-up and re-presented 2.5 years later with symptoms of tumour induced osteomalacia including immobility & multiple atraumatic fractures. Resolution of her clinical symptoms and metabolic abnormalities were seen after endoscopic resection of PMT. She remains disease free as of 1 year follow-up. This case highlights the challenges in diagnosing sinonasal PMT & clinical considerations in the management of PMT. Surgical resection remains the mainstay of treatment with adjuvant radiotherapy in cases of incomplete resection or recurrence. Post-operative surveillance includes clinical and biochemical surveillance with repeat FGF-23 levels.


[´Ý±â]